Study Stopped
Lack of funds
Efficacy of a Web-based Lifestyle Modification Program in Obese Patients With Cardiovascular Risk Factors
A 6-Month, Randomized Study to Evaluate the Efficacy of a Web-based Lifestyle Modification Program With and Without Telephone Counseling Support
1 other identifier
interventional
N/A
1 country
1
Brief Summary
To evaluate the effect of a 6-month web-based lifestyle modification program with and without telephone counseling versus usual care in obese patients with cardiovascular risk factors on:
- Weight Loss
- Waist circumference; blood pressure; total cholesterol, triglycerides, LDL-cholesterol, HDL-cholesterol; glucose and hemoglobin A1c; C-reactive protein.
- Physical activity and eating habits
- Quality of life
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Aug 2012
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2012
CompletedFirst Submitted
Initial submission to the registry
August 9, 2012
CompletedFirst Posted
Study publicly available on registry
August 14, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2013
CompletedFebruary 1, 2019
January 1, 2019
1 year
August 9, 2012
January 30, 2019
Conditions
Outcome Measures
Primary Outcomes (1)
Change in body weight from randomization to 6 months
6 months
Secondary Outcomes (5)
Changes in waist circumference
6 months
Changes in blood pressure
6 months
Changes in lipid parameters (total cholesterol, triglycerides, LDL-cholesterol, HDL-cholesterol)
6 months
Changes in glycemic parameters (glucose and hemoglobin A1c)
6 months
Changes in C-reactive protein
6 months
Other Outcomes (2)
Changes in lifestyle behaviors (physical activity and eating habits)
6 months
Changes in quality of life
6 months
Study Arms (3)
Control
NO INTERVENTIONSubjects assigned to the usual care group will receive general lifestyle recommendations as per their country standards of care.
Web
EXPERIMENTALAccess to a web-based lifestyle modification program of 6-month duration that covers all aspects of a healthy lifestyle including physical activity, nutrition and weight maintenance.
Web+
EXPERIMENTALAccess to a web-based lifestyle modification program of 6-month duration that covers all aspects of a healthy lifestyle including physical activity, nutrition and weight maintenance plus telephone counseling support by health coaches on a weekly or bi-weekly basis.
Interventions
Access to a web-based lifestyle modification program of 6-month duration that covers all aspects of a healthy lifestyle including physical activity, nutrition and weight maintenance plus telephone counseling support by health coaches on a weekly or bi-weekly basis.
Eligibility Criteria
You may qualify if:
- Male or female 25-70 years of age
- Obese (BMI ≥ 30 kg/m2 and \<40 kg/m2)
- At least 2 cardiovascular risk factors (diabetes, hypertension or dyslipidemia) i) Hypertension defined by a history of hypertension, treatment of hypertension or BP values \>140/90 mmHg in two consecutive office visits ii) High cholesterol defined by an LDL-C ≥130 mg/dL and/or HDL-C \<40 mg/dL and triglycerides ≥150 mg/dL iii) Type 2 Diabetes Mellitus defined by a history of diabetes, treatment of diabetes or fasting glucose ≥126 mg/dL in two consecutive office visits
- Participant must be willing and able to provide written informed consent
- Participant must be willing and able to comply with study related procedures
- Participant must have access to Internet and e-mail
You may not qualify if:
- Stage 1 or 2 on Patient Activation Measures tool
- Weight change of more than 5 kg during the 3 months preceding the screening visit
- History of bariatric surgery
- Fasting Plasma Glucose at screening \> 250 mg/dL (\> 13.9 mmol/L)
- Hemoglobin A1c at screening \>8.5%
- Treatment of type 2 diabetes with insulin (except for history of intermittent acute use, no more than 2 weeks usage in previous 6 months)
- Uncontrolled or inadequately controlled hypertension at the time of screening with blood pressure \>160/100 mmHg
- Secondary hypertension
- Changes in lipid, blood pressure or diabetes modifying agents including introduction, change in dose or cessation in the 3 months prior to Screening Visit
- Personal history of coronary heart disease, congestive heart failure, serious arrhythmias and stroke
- Cardiovascular, hepatic, neurological, endocrine disease, active malignant tumor or other major systemic disease making implementation of the protocol or interpretation of the study results difficult.
- Presence of any condition (medical, psychological, social, or geographical), actual or anticipated, that in the opinion of the Investigator would restrict or limit the patient's successful participation for the duration of the study
- Presence of history of cancer within the past five years with the exception of adequately treated localized basal cell skin cancer or in situ uterine cervical cancer
- Use of systemic glucocorticoids (excluding topical application or inhaled forms) for one week or more within 3 months prior to the time of screening
- Use of any investigational agent (drug, biologic, device) within 3 months prior to screening
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Clinica Bazterrica
Buenos Aires, Argentina
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Andres Digenio, MD
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Jefe de Prevencion y Rehabilitacion
Study Record Dates
First Submitted
August 9, 2012
First Posted
August 14, 2012
Study Start
August 1, 2012
Primary Completion
August 1, 2013
Study Completion
December 1, 2013
Last Updated
February 1, 2019
Record last verified: 2019-01